Viewing Study NCT07400094


Ignite Creation Date: 2026-03-26 @ 3:19 PM
Ignite Modification Date: 2026-03-31 @ 1:22 PM
Study NCT ID: NCT07400094
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-10
First Post: 2026-01-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC
Sponsor: National Medical Research Radiological Centre of the Ministry of Health of Russia
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module